Skip to Main Content

SCBIO 2017

  • sam patrick posted an article
    Building the business of life sciences in South Carolina has become the call to action of SCBIO... see more

    Building the business of life sciences in South Carolina has become the call to action and theme of the 2017 annual conference of the S.C. Biotechnology Organization (SCBIO).  The rapidly evolving statewide industry association is featured in this September 2017 issue of Charleston Business Magazine, and will be featured in October 2017 issues of Columbia Business and Greenville Business as well.  Click here for the full article.

  • sam patrick posted an article
    SCBIO has named Erin Ford as the organization's first VP see more

    SCBIO’s executive committee announced today that Erin Ford, currently the director of sales at Anderson-based Poly-Med Inc. and Chair of the Board of Directors of the South Carolina Biotechnology Industry Organization (SCBIO), is joining the non-profit life sciences industry organization as its inaugural Vice President.

    SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry already has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products.  The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.

    “Erin is an extraordinarily talented, multi-faceted executive with magnetic relationship-building skills, along with being a proven leader,” said SCBIO President/CEO, Sam Konduros.  “As I was vetting and interviewing a number of extremely worthy candidates for this critical executive position, it occurred to me that our board chair was the absolute perfect fit, and I felt humbly compelled to ask Erin to consider exploring the role.  To my and the Executive Committee’s great delight, she ultimately committed to bring her signature career to SCBIO on a full-time basis starting January 2nd.  We are extremely fortunate to have such a knowledgeable and seasoned pro like Erin join the executive team and hit the ground running in 2018, following a year of her outstanding leadership as our board chair.”

    Ms. Ford departs Poly-Med, a global innovation company that is developing absorbable polymers and constructs for the medical device industry, for her new role at SCBIO, where she will work closely with the CEO on various corporate strategies emanating from the organization’s 3 statewide offices.  Her comprehensive responsibilities will include serving as primary lead for SCBIO’s business operations, championing investor relations and existing industry strategies, and spearheading major integrated marketing initiatives.

    She previously served as a business recruitment officer at the Upstate SC Alliance, where she was the main point of contact for life sciences companies interested in expanding or locating in Upstate South Carolina, and gained in-depth economic development experience. While at the Upstate Alliance, Ms. Ford served as an ex-officio SCBIO board member from 2013-2015, and led a regional biosciences task force comprised of industry executives from across the region. She also has extensive television experience as a documentary producer and sportscaster, and received her B.A. in Communication from La Salle University in Philadelphia.

    "SCBIO presents a unique career opportunity to work in an arena whose constituent members and companies make a tangible difference in the quality of people's lives," said Ms. Ford. "Our hundreds of members include academic institutions, biotech companies, service providers, thought leaders, and economic development groups whose members are leading the research and development of innovative healthcare, industrial and environmental biotechnology and med-tech products that can transform and extend people’s lives.  While I have loved my time at Poly-Med, which served as an invaluable life science industry experience for my new career path with SCBIO, this unique opportunity to touch lives and grow South Carolina's knowledge economy was simply too powerful to pass up."

    Ms. Ford joins SCBIO's recently named President and CEO Sam Konduros atop the growing organization's leadership team.  Konduros, also a former SCBIO board member, assumed the leadership reins of the group earlier this year after departing Greenville Health System, where he ran the Research Development Corporation forging industry partnerships, developing economic development strategies, and helping doctors take their inventions to market. Previously, he was the first president of the Upstate SC Alliance, the Upstate region’s economic-development agency.

    The addition of Ms. Ford occurs as SCBIO continues to flex new muscles to advance and grow the business of life sciences in South Carolina.  It comes on the heels of the organization's recent restructuring and rebranding efforts, and its highly successful annual conference, which drew hundreds of industry leaders, national executives, academics, economic development organizations, government officials and others to Charleston October 24-26.  The organization has already attained record membership and investor levels, and recently formed a partnership with the South Carolina Department of Commerce to develop and implement strategic growth recommendations for the state’s fast-expanding industry.

    "This industry is at a critical time for accelerating our growth and impact in South Carolina and well beyond," said Ms. Ford.  "When you have such a unique opportunity, you have to seize the day and make positive things happen.  That's our goal."

    SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations.  SCBIO members include academic institutions, biotech companies, med-tech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.

  • sam patrick posted an article
    Governor honors Konduros during keynote address at packed life sciences conference see more

    SCBIO CEO Sam Konduros was presented with the Order of the Palmetto, the state's highest civilian honor, during SCBIO's annual conference at the Gaillard Center in Charleston last week.

    Governor McMaster was one of the featured keynote speakers at the gathering, where he extolled the state's virtues as a growing life sciences cluster.  Following his comments, he surprised Konduros and the crowd of nearly 300 life sciences executives and leaders by presenting the honor, citing Konduros’ long service to the state. 

    The Order of the Palmetto is the highest civilian honor in the State of South Carolina and is awarded for extraordinary lifetime service and achievements of national or statewide significance. The selections are screened and vetted by a bipartisan committee and then forwarded on to the governor for final consideration.  Governor John C. West presented the first Order of the Palmetto in the summer of 1971 as a way to recognize outstanding achievements, service, and contributions to South Carolina.

    Konduros, who became CEO at SCBIO about six months ago, says he was humbled by the honor.

    "I have had a love affair with South Carolina for as long as I can remember, so to receive the state's highest civilian honor directly from the governor -- in the midst of the SCBIO Annual Conference -- was one of the most humbling and overwhelming experiences of my life," he said. "I was beyond surprised, and am extraordinarily grateful."

    Konduros began serving as President and CEO of SCBIO (South Carolina Biotechnology Industry Organization) in Spring 2017, and has focused on leading the statewide organization to its next level of development. SCBIO is committed to building, advancing, and growing the life sciences industry in South Carolina, working closely with strategic partners from industry, academia, and the public/private sector - including complementary local, regional, and state economic development agencies such as the SC Department of Commerce.  SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations.

    Konduros has also served as Founder of SK Strategies, LLC - a Greenville-based consulting firm that specializes in economic development, public-private partnerships, integrated marketing and business development strategies for such clients as CU-ICAR, Clemson University, Greenville Health System, and KENTWOOL.  He formerly served as Executive Director of the Greenville Health Research Development Corporation (RDC), as well as Senior Project Manager for the SC Department of Commerce, Alfmeier Corporation’s Executive VP for North America, and Founding CEO of Upstate SC Alliance in past years.

    A licensed attorney since 1989, Konduros currently serves as board member and past chair of the Cancer Society of Greenville County, South State Bank Greenville Advisory Board, Palmetto Conservation Foundation board, and is a past executive committee/ and board member of the SC Chamber of Commerce.

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has an $11.4 billion economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products. 

    SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations – SCBIO members include hundreds of academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.

    For additional information on SCBIO, visit www.SCBIO.org

  • sam patrick posted an article
    Top speakers and brands are committing to attend SCBIO 2017 in Charleston this October; have you sig see more

    BIO global CEO Jim Greenwood will join South Carolina Governor Henry McMaster as featured luncheon speakers on the first full day of SCBIO 2017 – the annual conference bringing top leaders and executives from organizations across the life sciences industry to Charleston, South Carolina October 24–26.

    Mr. Greenwood will be addressing the gathering with a keynote presentation entitled “Global Trends for the Life Sciences Industry – and Implications for South Carolina” at lunch on October 25.  South Carolina Governor Henry McMaster will follow with a presentation entitled “Life Sciences Powered by Public/Private Partnership – A Strategic View from the Statehouse.”

    Dozens of top industry chief executives, leaders in government and higher education, biotechnology and pharma executives, and industry supporters from across America have already committed to attend SCBIO 2017 at Charleston’s Gaillard Auditorium, organizers confirmed today.  Among the committed speakers and panelists are Nephron Pharmaceuticals CEO Lou Kennedy, MUSC President David Cole, Clemson University President Jim Clements, USC President Harris Pastides, Medpoint CEO Chuck Crumpton, Belimed CEO Joseph McDonald, AVX Health Division executive Robert Fairey and numerous others.

    Themed “Building the Business of Life SCiences in SC”, the 2+ day conference draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion.  Committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, pharmaceuticals, diagnostics and testing, digital health and health IT, bio ag  and more.  While space is limited and advance registration is required, interested attendees can still register at http://scbio2017.eventbrite.com.

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has an $11.4 billion economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products. 

    SCBIO 2017 kicks off Tuesday evening with a Welcome Reception for conference registrants, speakers and sponsors on the rooftop terrace of the Grand Bohemian Hotel.  Wednesday will feature a full day of sessions beginning at breakfast with a greeting by Charleston Mayor John Tecklenburg and continuing through an evening reception.  The conference will wrap up Thursday at lunchtime. 

    “The life sciences industry has become a major driver of South Carolina’s economy,” noted South Carolina Secretary of Commerce Bobby Hitt recently. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, we know that this sector has tremendous growth potential, and we’re excited to be partnering with SCBIO to help life sciences continue to advance in South Carolina.”  SC Commerce is a Founding Partner of SCBIO and of the Conference.

    Among the leading biotech industry brands participating in the conference are Nephron Pharmaceutical, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Ritedose Corporation, Rhythmlink, Softbox, NCGS and SEMDA.  All of South Carolina’s research universities – MUSC, Clemson and the University of South Carolina – are attending, as is Greenville Health System and economic development entities including SCRA, the Upstate SC Alliance, the Charleston Regional Development Alliance and SiMT.

    As the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations – SCBIO members include hundreds of academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.

    For additional information on SCBIO, visit www.SCBIO.org.  To register for SCBIO 2017, visit http://scbio2017.eventbrite.com

  • sam patrick posted an article
    Hundreds of industry executives to convene Oct. 24-26 in Charleston, SC see more

    GREENVILLE, SC – Hundreds of industry executives, leaders in government and higher education, biotechnology and pharma executives, and industry supporters from across America will convene in Charleston, South Carolina for SCBIO 2017 – SCBIO’s Annual Conference -- October 24-26, 2017 at Charleston’s Gaillard Auditorium, organizers announced today.  Among the committed speakers and panelists are South Carolina Governor Henry McMaster, BIO Chief Executive Jim Greenwood, Nephron Pharmaceuticals CEO Lou Kennedy, MUSC President David Cole, and others.

    Early bird registration is now open for the conference, themed “Building the Business of Life SCiences in SC”, which draws attendees for intensive networking, innovation updates, opportunity discovery, partnership making and strategic discussion.  Registrants expected include top officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, pharmaceuticals, diagnostics and testing, digital health and health IT, bio ag  and more.  Interested attendees and sponsors can register at SCBIO 2017 Registration on Eventbrite for full details.  Advance registration is required, and space is limited.

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  SCBIO members are involved in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products.  The industry has an $11.4 billion economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the state’s burgeoning industry.

    SCBIO 2017 kicks off Tuesday evening with a Welcome Reception for conference registrants, speakers and sponsors on the rooftop terrace of the Grand Bohemian Hotel.  Wednesday will feature a full day of sessions beginning with a Welcome Breakfast, greeting by Charleston Mayor John Tecklenburg and an Industry CEO Panel.  A report on South Carolina’s exploding Life Sciences Industry featuring SCBIO CEO Sam Konduros and USC Darla Moore School of Business leader Dr. Joey Von Nessen will follow, as will a presentation by SC Deputy Secretary of Commerce Jennifer Fletcher.  SC Commerce is a Founding Partner of SCBIO and of the Conference.

    “The life sciences industry has become a major driver of South Carolina’s economy,” noted South Carolina Secretary of Commerce Bobby Hitt recently. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, we know that this sector has tremendous growth potential, and we’re excited to be partnering with SCBIO to help life sciences continue to advance in South Carolina.”

    Wednesday’s program continues with a second CEO panel of leaders from South Carolina’s biotech industry delivering insight on organizational challenges and opportunities – including presenting sponsor Nephron Pharmaceutical CEO, Lou Kennedy, whose company has invested close to $400 million and recently relocated their global headquarters to the Palmetto State.

    ”South Carolina is a great home for the life sciences cluster, and Nephron Pharmaceuticals is happy to be part of it – and we thank SCBIO for its leadership,” stated Kennedy. The industry CEO panel will be followed by a luncheon featuring a keynote by Jim Greenwood, CEO of BIO.  Comments from South Carolina Governor Henry McMaster will follow Mr. Greenwood’s presentation.

    Highlights of Wednesday afternoon will include presentations on the transformational role of the state’s research institutions in our knowledge economy featuring MUSC David Cole and leaders from the state’s other research universities, followed by an interactive panel discussion with nationally respected venture capitalists on attracting additional capital to the state.  A reception for all registrants will follow.

    Thursday will cap SCBIO 2017 with a breakfast event designed to engage conference attendees directly in the strategic discussion, catalyzed by a presentation on “Building SC’s Life Sciences Industry” delivered by CEOs of scaling-up life sciences companies.  An interactive SWOT session on the needs of the industry in South Carolina will follow, and Thursday will culminate with self-selected interactive and facilitated sessions at which each attendee can interface with industry leaders, panelists, presenters and stakeholders of their choosing.

    As the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations – SCBIO members include scores of academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related organizations whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.

    Committed sponsors of SCBIO 2017 include the South Carolina Department of Commerce; Nephron Pharmaceuticals; SCRA; Charleston Harbor Entrepreneur Center; KDS Commercial Real Estate; MUSC; the Charleston Regional Development Alliance; AVX; SiMT; Clemson University; University of South Carolina; the Upstate Alliance; VWR; SEMDA and many more.

    For additional information on SCBIO, visit www.SCBIO.org.  To register for SCBIO 2017, visit Event Brite and search “SCBIO 2017 annual conference”.